H.R. 8269
To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. McCormick, Richard [R-GA-7]
Bill Details
- Update Date
- Apr 15, 2026
- Update Date (incl. Text)
- Apr 15, 2026
- Origin Chamber
- House
- Bill Type
- HR
- Bill Number
- 8,269
- Congress
- 119
- Introduced Date
- Apr 14, 2026
- Is Law
- No
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: House floor actions
Introduced in House
Source: Library of Congress
Introduced in House
Source: Library of Congress
Energy and Commerce Committee
Ways and Means Committee